Selective Modulation of B-Cell Activation Markers CD86 and I-Ak on Murine Draining Lymph Node Cells Following Allergen or Irritant Treatment
It is well known that T cells are key effector cells in the development of allergic contact dermatitis. However, we and others have shown that mice exposed to contact allergens show a preferential increase in B lymphocytes in the draining lymph nodes (DLN) as seen by an increase in the percentage of...
Gespeichert in:
Veröffentlicht in: | Toxicology and applied pharmacology 1999-09, Vol.159 (2), p.142-151 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 151 |
---|---|
container_issue | 2 |
container_start_page | 142 |
container_title | Toxicology and applied pharmacology |
container_volume | 159 |
creator | Gerberick, G.Frank Cruse, Lynn W. Miller, Cathy M. Ridder, Gregg M. |
description | It is well known that T cells are key effector cells in the development of allergic contact dermatitis. However, we and others have shown that mice exposed to contact allergens show a preferential increase in B lymphocytes in the draining lymph nodes (DLN) as seen by an increase in the percentage of B220+ or IgG/IgM+ cells. The purpose of the present investigation was to determine whether chemical allergens, in contrast to irritants, would modulate B-cell activation markers, CD86 and I-Ak, on B cells isolated from DLN of treated mice using the local lymph node assay (LLNA) protocol. Mice were treated on the ears for 3 consecutive days with concentrations of allergens (1-chloro-2,4-dinitrobenzene, α-hexylcinnamaldehyde, 4-ethoxymethylene-2-phenyl-2-oxazoline-5-one, and trinitrochlorobenzene), or irritants (benzalkonium chloride and sodium lauryl sulfate), which caused an increase in the number of DLN cells. The DLN were excised 72 h following the final chemical treatment, and the cells were prepared for analysis by flow cytometry. In mice treated with allergens an increase in the median intensity of I-AK and CD86 on B220+ or IgG/IgM+ B cells was observed compared to mice treated with irritants or vehicles. Mice treated with allergens demonstrated an increase in the median intensity of CD86 on B220+ B cells that was dose dependent and peaked at 72 h following the final allergen treatment. The increase in the median intensity of I-AK also was dose dependent but peaked at 96 h. Finally, T and B cells isolated from both allergen- and irritant-treated mice demonstrated an increase in [3H]thymidine incorporation compared to vehicle-treated and naı̈ve mice at 72 h following the final chemical treatment. The results suggest that B cells isolated from DLN of allergen-treated mice are activated and proliferating. Analysis of B-cell activation markers may be useful in differentiating allergen and irritant responses in the draining lymph nodes of chemically treated mice. |
doi_str_mv | 10.1006/taap.1999.8734 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1006_taap_1999_8734</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0041008X99987343</els_id><sourcerecordid>10495778</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2828-8b2ea918337ec8d10c38bcd9bdf11709fda862f6a59a74c6447941cf3a1a97e23</originalsourceid><addsrcrecordid>eNp1kcFOGzEQhi1UVELaK0fkQ68b7LWzax9D0pRIoT0UJG6riT0LJo43sjepeAceurtaJLhwsjT_N2P7G0IuOJtwxoqrFmA_4VrriSqFPCEjznSRMSHEFzJiTPKMMfVwRs5TemaMaSn5V3LGmdTTslQj8voXPZrWHZHeNvbgoXVNoE1Nr7M5ek9nfTYUbyFuMSY6X6iCQrB0lc22tA8O0QWkiwguuPBI1y-7_RP93Vik_YxEl433zb8-mnmP8RG7GyJdxehaCC29iwjtDkP7jZzW4BN-fzvH5H75825-k63__FrNZ-vM5CpXmdrkCJorIUo0ynJmhNoYqze25rxkuragirwuYKqhlKaQstSSm1oAB11iLsZkMsw1sUkpYl3to9tBfKk4q3qtVa-16rVWvdau4XJo2B82O7Qf8MFjB_x4AyAZ8HWEYFx657RWIp92mBow7H53dBirZBwGg9bFbguVbdxnT_gPNq6UQw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Selective Modulation of B-Cell Activation Markers CD86 and I-Ak on Murine Draining Lymph Node Cells Following Allergen or Irritant Treatment</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Gerberick, G.Frank ; Cruse, Lynn W. ; Miller, Cathy M. ; Ridder, Gregg M.</creator><creatorcontrib>Gerberick, G.Frank ; Cruse, Lynn W. ; Miller, Cathy M. ; Ridder, Gregg M.</creatorcontrib><description>It is well known that T cells are key effector cells in the development of allergic contact dermatitis. However, we and others have shown that mice exposed to contact allergens show a preferential increase in B lymphocytes in the draining lymph nodes (DLN) as seen by an increase in the percentage of B220+ or IgG/IgM+ cells. The purpose of the present investigation was to determine whether chemical allergens, in contrast to irritants, would modulate B-cell activation markers, CD86 and I-Ak, on B cells isolated from DLN of treated mice using the local lymph node assay (LLNA) protocol. Mice were treated on the ears for 3 consecutive days with concentrations of allergens (1-chloro-2,4-dinitrobenzene, α-hexylcinnamaldehyde, 4-ethoxymethylene-2-phenyl-2-oxazoline-5-one, and trinitrochlorobenzene), or irritants (benzalkonium chloride and sodium lauryl sulfate), which caused an increase in the number of DLN cells. The DLN were excised 72 h following the final chemical treatment, and the cells were prepared for analysis by flow cytometry. In mice treated with allergens an increase in the median intensity of I-AK and CD86 on B220+ or IgG/IgM+ B cells was observed compared to mice treated with irritants or vehicles. Mice treated with allergens demonstrated an increase in the median intensity of CD86 on B220+ B cells that was dose dependent and peaked at 72 h following the final allergen treatment. The increase in the median intensity of I-AK also was dose dependent but peaked at 96 h. Finally, T and B cells isolated from both allergen- and irritant-treated mice demonstrated an increase in [3H]thymidine incorporation compared to vehicle-treated and naı&#x0308;ve mice at 72 h following the final chemical treatment. The results suggest that B cells isolated from DLN of allergen-treated mice are activated and proliferating. Analysis of B-cell activation markers may be useful in differentiating allergen and irritant responses in the draining lymph nodes of chemically treated mice.</description><identifier>ISSN: 0041-008X</identifier><identifier>EISSN: 1096-0333</identifier><identifier>DOI: 10.1006/taap.1999.8734</identifier><identifier>PMID: 10495778</identifier><identifier>CODEN: TXAPA9</identifier><language>eng</language><publisher>San Diego, CA: Elsevier Inc</publisher><subject>allergens ; Allergens - immunology ; Allergens - pharmacology ; Allergic diseases ; Animals ; Antibodies ; Antigens, CD - analysis ; B cells ; B-Lymphocytes - drug effects ; B7-2 Antigen ; Biological and medical sciences ; Biomarkers ; costimulatory molecules ; Dose-Response Relationship, Drug ; Ear, External - drug effects ; Female ; Flow Cytometry ; Histocompatibility Antigens Class II - analysis ; Immunoglobulin G - metabolism ; Immunoglobulin M - metabolism ; Immunoglobulins - metabolism ; Immunopathology ; irritants ; Irritants - immunology ; Irritants - pharmacology ; local lymph node assay ; Lymph Nodes - drug effects ; Lymphocyte Activation ; Medical sciences ; Membrane Glycoproteins - analysis ; MHC class II ; Mice ; Mice, Inbred CBA ; Skin allergic diseases. Stinging insect allergies ; T cells ; T-Lymphocytes - drug effects ; Time Factors</subject><ispartof>Toxicology and applied pharmacology, 1999-09, Vol.159 (2), p.142-151</ispartof><rights>1999 Academic Press</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2828-8b2ea918337ec8d10c38bcd9bdf11709fda862f6a59a74c6447941cf3a1a97e23</citedby><cites>FETCH-LOGICAL-c2828-8b2ea918337ec8d10c38bcd9bdf11709fda862f6a59a74c6447941cf3a1a97e23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1006/taap.1999.8734$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1998325$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10495778$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gerberick, G.Frank</creatorcontrib><creatorcontrib>Cruse, Lynn W.</creatorcontrib><creatorcontrib>Miller, Cathy M.</creatorcontrib><creatorcontrib>Ridder, Gregg M.</creatorcontrib><title>Selective Modulation of B-Cell Activation Markers CD86 and I-Ak on Murine Draining Lymph Node Cells Following Allergen or Irritant Treatment</title><title>Toxicology and applied pharmacology</title><addtitle>Toxicol Appl Pharmacol</addtitle><description>It is well known that T cells are key effector cells in the development of allergic contact dermatitis. However, we and others have shown that mice exposed to contact allergens show a preferential increase in B lymphocytes in the draining lymph nodes (DLN) as seen by an increase in the percentage of B220+ or IgG/IgM+ cells. The purpose of the present investigation was to determine whether chemical allergens, in contrast to irritants, would modulate B-cell activation markers, CD86 and I-Ak, on B cells isolated from DLN of treated mice using the local lymph node assay (LLNA) protocol. Mice were treated on the ears for 3 consecutive days with concentrations of allergens (1-chloro-2,4-dinitrobenzene, α-hexylcinnamaldehyde, 4-ethoxymethylene-2-phenyl-2-oxazoline-5-one, and trinitrochlorobenzene), or irritants (benzalkonium chloride and sodium lauryl sulfate), which caused an increase in the number of DLN cells. The DLN were excised 72 h following the final chemical treatment, and the cells were prepared for analysis by flow cytometry. In mice treated with allergens an increase in the median intensity of I-AK and CD86 on B220+ or IgG/IgM+ B cells was observed compared to mice treated with irritants or vehicles. Mice treated with allergens demonstrated an increase in the median intensity of CD86 on B220+ B cells that was dose dependent and peaked at 72 h following the final allergen treatment. The increase in the median intensity of I-AK also was dose dependent but peaked at 96 h. Finally, T and B cells isolated from both allergen- and irritant-treated mice demonstrated an increase in [3H]thymidine incorporation compared to vehicle-treated and naı&#x0308;ve mice at 72 h following the final chemical treatment. The results suggest that B cells isolated from DLN of allergen-treated mice are activated and proliferating. Analysis of B-cell activation markers may be useful in differentiating allergen and irritant responses in the draining lymph nodes of chemically treated mice.</description><subject>allergens</subject><subject>Allergens - immunology</subject><subject>Allergens - pharmacology</subject><subject>Allergic diseases</subject><subject>Animals</subject><subject>Antibodies</subject><subject>Antigens, CD - analysis</subject><subject>B cells</subject><subject>B-Lymphocytes - drug effects</subject><subject>B7-2 Antigen</subject><subject>Biological and medical sciences</subject><subject>Biomarkers</subject><subject>costimulatory molecules</subject><subject>Dose-Response Relationship, Drug</subject><subject>Ear, External - drug effects</subject><subject>Female</subject><subject>Flow Cytometry</subject><subject>Histocompatibility Antigens Class II - analysis</subject><subject>Immunoglobulin G - metabolism</subject><subject>Immunoglobulin M - metabolism</subject><subject>Immunoglobulins - metabolism</subject><subject>Immunopathology</subject><subject>irritants</subject><subject>Irritants - immunology</subject><subject>Irritants - pharmacology</subject><subject>local lymph node assay</subject><subject>Lymph Nodes - drug effects</subject><subject>Lymphocyte Activation</subject><subject>Medical sciences</subject><subject>Membrane Glycoproteins - analysis</subject><subject>MHC class II</subject><subject>Mice</subject><subject>Mice, Inbred CBA</subject><subject>Skin allergic diseases. Stinging insect allergies</subject><subject>T cells</subject><subject>T-Lymphocytes - drug effects</subject><subject>Time Factors</subject><issn>0041-008X</issn><issn>1096-0333</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kcFOGzEQhi1UVELaK0fkQ68b7LWzax9D0pRIoT0UJG6riT0LJo43sjepeAceurtaJLhwsjT_N2P7G0IuOJtwxoqrFmA_4VrriSqFPCEjznSRMSHEFzJiTPKMMfVwRs5TemaMaSn5V3LGmdTTslQj8voXPZrWHZHeNvbgoXVNoE1Nr7M5ek9nfTYUbyFuMSY6X6iCQrB0lc22tA8O0QWkiwguuPBI1y-7_RP93Vik_YxEl433zb8-mnmP8RG7GyJdxehaCC29iwjtDkP7jZzW4BN-fzvH5H75825-k63__FrNZ-vM5CpXmdrkCJorIUo0ynJmhNoYqze25rxkuragirwuYKqhlKaQstSSm1oAB11iLsZkMsw1sUkpYl3to9tBfKk4q3qtVa-16rVWvdau4XJo2B82O7Qf8MFjB_x4AyAZ8HWEYFx657RWIp92mBow7H53dBirZBwGg9bFbguVbdxnT_gPNq6UQw</recordid><startdate>19990901</startdate><enddate>19990901</enddate><creator>Gerberick, G.Frank</creator><creator>Cruse, Lynn W.</creator><creator>Miller, Cathy M.</creator><creator>Ridder, Gregg M.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19990901</creationdate><title>Selective Modulation of B-Cell Activation Markers CD86 and I-Ak on Murine Draining Lymph Node Cells Following Allergen or Irritant Treatment</title><author>Gerberick, G.Frank ; Cruse, Lynn W. ; Miller, Cathy M. ; Ridder, Gregg M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2828-8b2ea918337ec8d10c38bcd9bdf11709fda862f6a59a74c6447941cf3a1a97e23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>allergens</topic><topic>Allergens - immunology</topic><topic>Allergens - pharmacology</topic><topic>Allergic diseases</topic><topic>Animals</topic><topic>Antibodies</topic><topic>Antigens, CD - analysis</topic><topic>B cells</topic><topic>B-Lymphocytes - drug effects</topic><topic>B7-2 Antigen</topic><topic>Biological and medical sciences</topic><topic>Biomarkers</topic><topic>costimulatory molecules</topic><topic>Dose-Response Relationship, Drug</topic><topic>Ear, External - drug effects</topic><topic>Female</topic><topic>Flow Cytometry</topic><topic>Histocompatibility Antigens Class II - analysis</topic><topic>Immunoglobulin G - metabolism</topic><topic>Immunoglobulin M - metabolism</topic><topic>Immunoglobulins - metabolism</topic><topic>Immunopathology</topic><topic>irritants</topic><topic>Irritants - immunology</topic><topic>Irritants - pharmacology</topic><topic>local lymph node assay</topic><topic>Lymph Nodes - drug effects</topic><topic>Lymphocyte Activation</topic><topic>Medical sciences</topic><topic>Membrane Glycoproteins - analysis</topic><topic>MHC class II</topic><topic>Mice</topic><topic>Mice, Inbred CBA</topic><topic>Skin allergic diseases. Stinging insect allergies</topic><topic>T cells</topic><topic>T-Lymphocytes - drug effects</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gerberick, G.Frank</creatorcontrib><creatorcontrib>Cruse, Lynn W.</creatorcontrib><creatorcontrib>Miller, Cathy M.</creatorcontrib><creatorcontrib>Ridder, Gregg M.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Toxicology and applied pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gerberick, G.Frank</au><au>Cruse, Lynn W.</au><au>Miller, Cathy M.</au><au>Ridder, Gregg M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Selective Modulation of B-Cell Activation Markers CD86 and I-Ak on Murine Draining Lymph Node Cells Following Allergen or Irritant Treatment</atitle><jtitle>Toxicology and applied pharmacology</jtitle><addtitle>Toxicol Appl Pharmacol</addtitle><date>1999-09-01</date><risdate>1999</risdate><volume>159</volume><issue>2</issue><spage>142</spage><epage>151</epage><pages>142-151</pages><issn>0041-008X</issn><eissn>1096-0333</eissn><coden>TXAPA9</coden><abstract>It is well known that T cells are key effector cells in the development of allergic contact dermatitis. However, we and others have shown that mice exposed to contact allergens show a preferential increase in B lymphocytes in the draining lymph nodes (DLN) as seen by an increase in the percentage of B220+ or IgG/IgM+ cells. The purpose of the present investigation was to determine whether chemical allergens, in contrast to irritants, would modulate B-cell activation markers, CD86 and I-Ak, on B cells isolated from DLN of treated mice using the local lymph node assay (LLNA) protocol. Mice were treated on the ears for 3 consecutive days with concentrations of allergens (1-chloro-2,4-dinitrobenzene, α-hexylcinnamaldehyde, 4-ethoxymethylene-2-phenyl-2-oxazoline-5-one, and trinitrochlorobenzene), or irritants (benzalkonium chloride and sodium lauryl sulfate), which caused an increase in the number of DLN cells. The DLN were excised 72 h following the final chemical treatment, and the cells were prepared for analysis by flow cytometry. In mice treated with allergens an increase in the median intensity of I-AK and CD86 on B220+ or IgG/IgM+ B cells was observed compared to mice treated with irritants or vehicles. Mice treated with allergens demonstrated an increase in the median intensity of CD86 on B220+ B cells that was dose dependent and peaked at 72 h following the final allergen treatment. The increase in the median intensity of I-AK also was dose dependent but peaked at 96 h. Finally, T and B cells isolated from both allergen- and irritant-treated mice demonstrated an increase in [3H]thymidine incorporation compared to vehicle-treated and naı&#x0308;ve mice at 72 h following the final chemical treatment. The results suggest that B cells isolated from DLN of allergen-treated mice are activated and proliferating. Analysis of B-cell activation markers may be useful in differentiating allergen and irritant responses in the draining lymph nodes of chemically treated mice.</abstract><cop>San Diego, CA</cop><pub>Elsevier Inc</pub><pmid>10495778</pmid><doi>10.1006/taap.1999.8734</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0041-008X |
ispartof | Toxicology and applied pharmacology, 1999-09, Vol.159 (2), p.142-151 |
issn | 0041-008X 1096-0333 |
language | eng |
recordid | cdi_crossref_primary_10_1006_taap_1999_8734 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | allergens Allergens - immunology Allergens - pharmacology Allergic diseases Animals Antibodies Antigens, CD - analysis B cells B-Lymphocytes - drug effects B7-2 Antigen Biological and medical sciences Biomarkers costimulatory molecules Dose-Response Relationship, Drug Ear, External - drug effects Female Flow Cytometry Histocompatibility Antigens Class II - analysis Immunoglobulin G - metabolism Immunoglobulin M - metabolism Immunoglobulins - metabolism Immunopathology irritants Irritants - immunology Irritants - pharmacology local lymph node assay Lymph Nodes - drug effects Lymphocyte Activation Medical sciences Membrane Glycoproteins - analysis MHC class II Mice Mice, Inbred CBA Skin allergic diseases. Stinging insect allergies T cells T-Lymphocytes - drug effects Time Factors |
title | Selective Modulation of B-Cell Activation Markers CD86 and I-Ak on Murine Draining Lymph Node Cells Following Allergen or Irritant Treatment |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T12%3A34%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Selective%20Modulation%20of%20B-Cell%20Activation%20Markers%20CD86%20and%20I-Ak%20on%20Murine%20Draining%20Lymph%20Node%20Cells%20Following%20Allergen%20or%20Irritant%20Treatment&rft.jtitle=Toxicology%20and%20applied%20pharmacology&rft.au=Gerberick,%20G.Frank&rft.date=1999-09-01&rft.volume=159&rft.issue=2&rft.spage=142&rft.epage=151&rft.pages=142-151&rft.issn=0041-008X&rft.eissn=1096-0333&rft.coden=TXAPA9&rft_id=info:doi/10.1006/taap.1999.8734&rft_dat=%3Cpubmed_cross%3E10495778%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/10495778&rft_els_id=S0041008X99987343&rfr_iscdi=true |